Center for Biologics Evaluation and Research
The Center for Biologics Evaluation and Research is one of six main centers for the U.S. Food and Drug Administration, which is a part of the U.S. Department of Health and Human Services. The current Director of CBER is Peter Marks, M.D., PhD. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Center for Biologics Evaluation and Research, United States, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
64%
Total
Publications
4.6K
Total Open
Publications
3K
Total
Citations
212K
Open Access
Percentage
64%
Total
Publications
4.6K
Total Open
Publications
3K
Total
Citations
212K
Breakdown
Publisher Open
16%
Both
33%
Other Platform Open
15%
Closed
36%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 37%
832
Hybrid 24%
557
No Guarantees 39%
877
Other Platform Open
Domain 92%
2.1K
Public 13%
284
Institution 11%
257
Preprint 7%
155
Other Internet 6%
130
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 2.1K |
Europe PMC | Domain | 1.5K |
Semantic Scholar | Public | 249 |
bioRxiv | Preprint | 99 |
DOI | Other Internet | 69 |
Figshare | Public | 47 |
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI | Institution | 37 |
medRxiv | Preprint | 35 |
CiteSeer X | Other Internet | 28 |
University of Zurich - Zurich Open Repository and Archive | Institution | 18 |